Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Da-Cheng-Qi Decoction in Severe Acute Pancreatitis
NCT07816900Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Apr 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of Dachengqi Decoction in acute pancreatitis (AP) and Intra-abdominal hypertension (IAH) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Change in Intra-abdominal Pressure at Day 7. Started Apr 2026; status: completed.
02
Drugs
Dachengqi Decoction
03
Conditions
acute pancreatitis (AP)Intra-abdominal hypertension (IAH)
Beyond the preview
Go deeper on NCT07816900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816900.